Diseases, Conditions, Syndromes

Study provides basis for personalized hepatitis C aftercare

Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation with researchers from Spain, a research team led ...

Immunology

Immune therapies against chronic hepatitis B

Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...

Diseases, Conditions, Syndromes

A roadmap for the future of hepatitis B therapy development

Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...

Diseases, Conditions, Syndromes

Australians with hepatitis B are slipping through the cracks

The current system of only screening risk groups for hepatitis B is failing a third of people living with the chronic disease in Australia, according to the authors of a Perspective published today by the Medical Journal ...

page 6 from 35